Journals / The Anatolian Journal of Cardiology / 2020 / Cilt: 23 - Sayı: 4

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm

Pages
228–232
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Binary logistic regression analysis of all patients showed that ADMA concentration was the only predictor for RAS (odds ratio=1.142;95% confidence interval=1.061–1.228; p<0.001).Conclusion: It was found that the ADMA concentration of the patients in the RAS group was elevated compared to that of controls.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The use of the radial approach in coronary angiography or percutaneous coronary intervention has increased owing to its advantagesover the femoral approach such as rapid patient mobilization and improved patient comfort.
📊
Key Findings & Data:This study aimed to evaluate the relationship between ADMA levels and RAS in radial artery access.Methods: This study included 155 patients (89 males and 66 females) who underwent transradial coronary angiography between January 2016and June 2016.
💡
Conclusion & Impact:Binary logistic regression analysis of all patients showed that ADMA concentration was the only predictor for RAS (odds ratio=1.142;95% confidence interval=1.061–1.228; p<0.001).Conclusion: It was found that the ADMA concentration of the patients in the RAS group was elevated compared to that of controls.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The use of the radial approach in coronary angiography or percutaneous coronary intervention has increased owing to its advantagesover the femoral approach such as rapid patient mobilization and improved patient comfort. However, radial artery spasm (RAS) that occurs during the procedure is a crucial factor in transradial approach failure and access site switch. Asymmetric dimethylarginine (ADMA) is a naturallyoccurring, modified amino acid that inhibits nitric oxide (NO) production. High ADMA levels may reduce arterial elasticity especially in smallarteries like the radial artery. This study aimed to evaluate the relationship between ADMA levels and RAS in radial artery access.Methods: This study included 155 patients (89 males and 66 females) who underwent transradial coronary angiography between January 2016and June 2016. The ADMA level in the plasma was determined using a quantitative sandwich enzyme immunoassay technique.Results: RAS was observed in 16 of the 155 patients (10.1%). The RAS was found to be more frequent in female patients (17.9% for women vs.4.4% for men, p=0.019). The plasma concentration of ADMA in the RAS group was significantly higher than that in the control group [22.1 ng/mL(12.1–37.8) vs. 9.2 ng/mL (5.9–14.8), p<0.001]. Moreover, the plasma concentration of ADMA was significantly higher in patients with RAS amongfemale patients [20.4 ng/mL (12.1–44.9) vs. 9.9 ng/mL (6.2–16.6); p=0.002] and among male patients [25.2 ng/mL (13.7–35.4) vs. 8.2 ng/mL (5.9–12.8);p=0.007]. Binary logistic regression analysis of all patients showed that ADMA concentration was the only predictor for RAS (odds ratio=1.142;95% confidence interval=1.061–1.228; p<0.001).Conclusion: It was found that the ADMA concentration of the patients in the RAS group was elevated compared to that of controls. The findingsindicated that elevated ADMA concentrations could predict RAS that may occur. (Anatol J Cardiol 2020; 23: 228-32)

🔖

Cite This Article

KOCAYİĞİT, İ., ÇAKAR, M. A., KAHYAOĞLU, B., AKSOY, M. N. M., TATLI, E., AKDEMİR, R. (2020). The relationship between serum asymmetric dimethylarginine levels and radial artery spasm. The Anatolian Journal of Cardiology, Cilt: 23 - Sayı: 4, 228–232. https://ajindex.com/articles/365225

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Feldman DN, Swaminathan RV, Kaltenbach LA, Baklanov DV, Kim LK, Wong SC, et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012). Circulation 2013; 127: 2295-306
  2. Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G, et al. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. JACC Cardiovasc Interv 2016; 9: 1419-34
  3. Mann T, Cubeddu G, Bowen J, Schneider JE, Arrowood M, Newman WN, et al. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol 1998; 32: 572-6
  4. Cooper CJ, El-Shiekh RA, Cohen DJ, Blaesing L, Burket MW, Basu A, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J 1999; 138 (3 Pt 1): 430-6
  5. Abdelaal E, Brousseau-Provencher C, Montminy S, Plourde G, MacHaalany J, Bataille Y, et al.; Interventional Cardiologists at Quebec Heart-Lung Institute. Risk score, causes, and clinical impact of failure of transradial approach for percutaneous coronary interventions. JACC Cardiovasc Interv 2013; 6: 1129-37
  6. He GW, Yang CQ. Characteristics of adrenoreceptors in the human radial artery: clinical implications. J Thorac Cardiovasc Surg 1998; 115: 1136-41
  7. Kiemeneij F, Vajifdar BU, Eccleshall SC, Laarman G, Slagboom T, van der Wieken R. Evaluation of a spasmolytic cocktail to prevent radial artery spasm during coronary procedures. Catheter Cardiovasc Interv 2003; 58: 281-4
  8. Jia DA, Zhou YJ, Shi DM, Liu YY, Wang JL, Liu XL, et al. Incidence and predictors of radial artery spasm during transradial coronary angiography and intervention. Chin Med J 2010; 123: 843–7
  9. Fukuda N, Iwahara S, Harada A, Yokoyama S, Akutsu K, Takano M, et al. Vasospasms of the radial artery after the transradial approach for coronary angiography and angioplasty. Jpn Heart J 2004; 45: 723-31
  10. Sibal L, Agarwal SC, Home PD, Boger RH. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev 2010; 6: 82-90
  11. Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358: 2127-8
  12. Böger RH, Maas R, Schulze